Jan Taton
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Treatment and Management 5
- Diabetes Management and Research 4
- Natural Antidiabetic Agents Studies 3
-
- Diet and metabolism studies 6
- Co-authors
- Anna Czech (16 shared papers)Paweł Piątkiewicz (7 shared papers)Miluše Hertlová (1 shared paper)Domenico Fedele (1 shared paper)Jindřich Olšovský (1 shared paper)Jacek Manitius (1 shared paper)Giovanni Gambaro (1 shared paper)Władysław Grzeszczak (1 shared paper)
- Journals
- Diabetologia (4 papers)Archivum Immunologiae et Therapiae Experimentalis (2 papers)The Lancet (2 papers)Metabolism (1 paper)Novartis Foundation symposium (1 paper)
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
Jan Taton
34 papers receiving 3.6k citations
Jan Taton's Hit Papers
Peers
Comparison fields: 5 of 108
- Endocrinology, Diabetes and Metabolism 2.1k
- Cardiology and Cardiovascular Medicine 719
- Nephrology 143
- Molecular Biology 1.3k
- Pharmacology 276
Countries citing papers authored by Jan Taton
This map shows the geographic impact of Jan Taton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Taton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Taton more than expected).
Fields of papers citing papers by Jan Taton
This network shows the impact of papers produced by Jan Taton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Taton. The network helps show where Jan Taton may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Taton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Hit paper breakdown → | 2005 | 3391 |
| 2 | 2002 | 161 | |
| 3 | 2003 | 121 | |
| 4 | 1999 | 70 | |
| 5 | 2004 | 48 | |
| 6 | 1964 | 26 | |
| 7 | 2007 | 23 | |
| 8 | Investigations of cellular glucose transport and its regulation under the influence of insulin in human peripheral blood lymphocytes. | 2010 | 18 |
| 9 | 1975 | 13 | |
| 10 | Insulin as the main regulator of cellular glucose utilization--aetiological aspects of insulin resistance. | 2011 | 10 |
| 11 | 2005 | 9 | |
| 12 | 1988 | 9 | |
| 13 | 1972 | 8 | |
| 14 | 1970 | 7 | |
| 15 | 2009 | 4 | |
| 16 | 1976 | 3 | |
| 17 | How recombinant insulin analogs improve insulin therapy of diabetes mellitus: pathophysiology, clinical practice and recommendations. | 2001 | 3 |
| 18 | 2003 | 2 | |
| 19 | [Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus]. | 1992 | 2 |
| 20 | Does cellular glucose transport respond to a controlled diet and sulfonylurea therapy in type 2 diabetes mellitus? | 2010 | 2 |
About Jan Taton
Jan Taton is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Genetics, Cardiology and Cardiovascular Medicine and Behavioral Neuroscience, having authored 43 papers that have together received 4.0k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (8 papers), Diabetes and associated disorders (6 papers), Diet and metabolism studies (6 papers), Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers), Natural Antidiabetic Agents Studies (3 papers), Nutrition and Health Studies (3 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Cardiology and Cardiovascular Medicine (719 citations), Nephrology (143 citations), Molecular Biology (1.3k citations) and Pharmacology (276 citations). Jan Taton has collaborated with scholars based in Poland, United States and France. Frequent co-authors include Anna Czech, Paweł Piątkiewicz, Miluše Hertlová, Domenico Fedele, Jindřich Olšovský, Jacek Manitius, Giovanni Gambaro, Władysław Grzeszczak, Jan Škrha and Stanisław Czekałski. Their work appears in journals such as Diabetologia, Archivum Immunologiae et Therapiae Experimentalis, The Lancet, Metabolism and Novartis Foundation symposium.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.